Literature DB >> 1680332

Transfection with SV40 gene of human pancreatic endocrine cells.

G Soldevila1, M Buscema, V Marini, R Sutton, R F James, S R Bloom, R P Robertson, R Mirakian, R Pujol-Borrell, G F Bottazzo.   

Abstract

At present, only islet cell lines of animal origin have been successfully generated (e.g. RIN, HIT). A fully differentiated human beta cell line would be advantageous for diabetes research. We now report the generation of a human endocrine pancreatic cell line obtained by transfection using a plasmid containing the early region of SV40 viral DNA. Viral integration and transcription was assessed by Southern and Northern blotting. This cell line has been growing continuously for more than 2 years and maintains several of the characteristics of the parental cells from which they were generated. The presence of Neuron Specific Enolase, Protein Gene Product 9.5, cytokeratin, microvilli, cytoplasmic electrodense granules and the secretion of insulin, glucagon and somatostatin supports the neuroendocrine origin of this cell line. However, hormone production progressively decreased and finally stopped at passage 8. Flow cytometric analysis showed that HLA expression in this cell line is readily induced by IFN-gamma and modulated by TNF-alpha. The establishment of this human endocrine cell line indicates the feasibility of immortalizing human islets by transfection with viral oncogenes. To obtain a fully differentiated cell line it may be necessary to use other DNA constructs which immortalize the cells without fully transforming their phenotype.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680332     DOI: 10.1016/0896-8411(91)90154-5

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  8 in total

1.  Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion.

Authors:  Jane T McCluskey; Muhajir Hamid; Hong Guo-Parke; Neville H McClenaghan; Ramon Gomis; Peter R Flatt
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells.

Authors:  M Vives-Pi; N Somoza; J Fernández-Alvarez; F Vargas; P Caro; A Alba; R Gomis; M O Labeta; R Pujol-Borrell
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

3.  Analysis of islet cell antibodies reactivity to a human islet cell line.

Authors:  A Muñoz; T Gallart; R Gomis
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256

Review 4.  Immune-mediated β-cell death in type 1 diabetes: lessons from human β-cell lines.

Authors:  Yaíma L Lightfoot; Jing Chen; Clayton E Mathews
Journal:  Eur J Clin Invest       Date:  2012-08-25       Impact factor: 4.686

5.  Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans.

Authors:  T Yoshida; D Hanahan
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

6.  Resveratrol and curcumin enhance pancreatic β-cell function by inhibiting phosphodiesterase activity.

Authors:  Michael Rouse; Antoine Younès; Josephine M Egan
Journal:  J Endocrinol       Date:  2014-11       Impact factor: 4.286

7.  Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient mice.

Authors:  Alastair D Green; Srividya Vasu; Neville H McClenaghan; Peter R Flatt
Journal:  World J Diabetes       Date:  2016-11-15

8.  A new strategy to generate functional insulin-producing cell lines by somatic gene transfer into pancreatic progenitors.

Authors:  Philippe Ravassard; Yasmine Hazhouz; Severine Pechberty; Jacques Mallet; Paul Czernichow; Raphael Scharfmann
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.